Literature DB >> 23481116

Clinical profile of Spanish postmenopausal women with a diagnosis of osteoporosis and risk factors for endometrial pathology, breast cancer, and cardiovascular disease.

Santiago Palacios1, José Luis Neyro, José Chaves Puertas, Susana Fernandez de Cabo.   

Abstract

OBJECTIVE: GINERISK was designed to assess the clinical profile of Spanish postmenopausal women with a diagnosis of osteoporosis and to establish the presence of other risk factors.
METHODS: In this Spanish cross-sectional, epidemiological, observational study, gynecologists sequentially invited postmenopausal women with osteoporosis under their care to complete a predefined questionnaire during a routine visit. Risk factors for bone fractures, endometrial pathology, breast cancer, and cardiovascular disease were assessed.
RESULTS: In addition to being postmenopausal and having diagnosed osteoporosis, 49.8% (2,070/4,157) of eligible participants had one or more risk factors for bone fractures, 96.8% (4,023/4,157) had one or more risk factors for breast cancer, and 83.4% (3,469/4,157) had one or more risk factors for cardiovascular disease. Furthermore, 20.1% (n = 835) of the women presented with high cardiovascular risk, 16.6% (n = 692) were at high risk for bone fractures, and 14.5% (n = 423) were at high risk for developing breast cancer in the next 5 years, whereas only 9.2% (n = 301) of participants were identified as having high endometrial risk.
CONCLUSIONS: In addition to the increased risk of bone fractures, women with osteoporosis are also at risk for endometrial pathology, breast cancer, and cardiovascular disease. These risks should be evaluated and taken into consideration when choosing an osteoporosis treatment for postmenopausal women.

Entities:  

Mesh:

Year:  2013        PMID: 23481116     DOI: 10.1097/GME.0b013e318280a2f6

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  1 in total

1.  Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study.

Authors:  Josep Darbà; Lisette Kaskens; Nuria Pérez-Álvarez; Santiago Palacios; José Luis Neyro; Javier Rejas
Journal:  BMC Public Health       Date:  2015-04-02       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.